Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Eli Lilly
Biotech
DNA med-focused biotech Seawolf surfaces with $1.2B Sanofi pact
Gene therapy biotech Seawolf has emerged from the deep with $100 million to fuel its DNA therapeutic ambitions and a billion-dollar deal with Sanofi.
Michael Gibney
Nov 16, 2026 5:00am
AHA: Novartis’ Lp(a) drug shows zero benefit
Nov 7, 2026 9:50am
Lilly International's Patrik Jonsson to retire—Chutes & Ladders
Oct 30, 2026 8:30am
Lilly scraps ph. 2 Alzheimer's program after drug falls short
Oct 29, 2026 2:09pm
Lilly’s retatrutide tops Ozempic in ph. 3 diabetes showdown
Oct 28, 2026 7:45am
ESMO: Lilly ADC sees 79% ORR in competitive ovarian cancer space
Oct 24, 2026 2:30am